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Background: The growing population living with chronic conditions calls for efficient healthcare-planning and
effective care. Implementing disease-management-programmes is one option for responding to this demand.
Knowledge is scarce about the effect of implementation processes and their effect on patients; only few studies
have reported the effectiveness of disease-management-programmes targeting patients with chronic obstructive
pulmonary disease (COPD). The objective of this paper was to determine the effect on healthcare-utilization of an
active implementation model for a disease-management-programme for patients with one of the major
multimorbidity diseases, COPD.
Methods: The standard implementation of a new disease-management-programme for COPD was ongoing during
the study-period from November 2008 to November 2010 in the Central Denmark Region. We wanted to test a
strategy using Breakthrough Series, academic detailing and lists of patients with COPD. It targeted GPs and three
hospitals serving approx. 60,000 inhabitants aged 35 or older and included interventions directed at professionals,
organisations and patients. The study was a non-blinded block- and cluster-randomised controlled trial with
GP-practices as the unit of randomisation. In Ringkoebing-Skjern Municipality, Denmark, 16 GP-practices involving
38 GPs were randomised to either the intervention-group or the control-group. A comparable neighbouring
municipality acted as an external-control-group which included nine GP-practices with 25 GPs. An algorithm based
on health-registry-data on lung-related contacts to the healthcare-system identified 2,736 patients who were alive
at the end of the study-period. The population included in this study counted 1,372 (69.2%) patients who
responded to the baseline questionnaire and confirmed their COPD diagnosis; 458 (33.4%) patients were from the
intervention-group, 376 (27.4%) from the control-group and 538(39.2%) from the external-control-group. The
primary outcome was adherence to the disease-management-programme measured at patient-level by use of
specific services from general practice. Secondary outcomes were use of out-of-hours-services, outpatient-clinic, and
emergency-department and hospital-admissions.
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Results: The intervention practices provided more planned preventive consultations, additional preventive
consultations and spirometries than non-intervention practices. A comparison of the development in the
intervention practices with the development in the control-practices showed that the intervention resulted in more
planned preventive-consultations, fewer conventional consultations and fewer patients admitted without a lung-
related-diagnosis.
Conclusions: Use of the active implementation model for the disease-management-programme for COPD changed
the healthcare utilization in accordance with the programme.
Trial registration: Clinicaltrials.gov identifier: NCT01228708.
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The number of people living with chronic conditions is
growing as a result of lifestyle, increased life-expectancy,
improved treatment options and growing diagnostic activity
[1]. This situation demands efficient healthcare planning
and effective care. Danish healthcare is tax-financed and
citizens therefore enjoy free use of healthcare at the point
of care. The nearly 3,600 general practitioners (GPs) are
gatekeepers for access to most of the healthcare system.
The GPs operate as independent contractors under a sys-
tem of five regions and are remunerated on a combination
of fee-for-service and capitation basis (75/25). Each of the
98 Danish municipalities is responsible for providing re-
habilitation services and preventive care for their citizens.
The five Danish regions are responsible for services from
hospitals and general practice.
The Danish Health and Medicines Authority estimates
that 80% of healthcare costs are spent on people living
with one or more chronic conditions [2]. It has been ar-
gued that healthcare may be improved and public spend-
ing reduced by implementation of an efficient strategy
that ensures seamless care for patients through the con-
certed effort of general practices (GP practices), hospitals
and the municipalities [3-6]. Only few studies have investi-
gated the economy and the healthcare utilization of the in-
tegrated care programmes [7]. Wennberg has dismissed the
idea that ”more is better” within healthcare provision [8],
but argues that the care provided rather needs to be
targeted and focused.
Chronic obstructive pulmonary disease (COPD) is
an important non-communicable disease. It ranks as
the fifth leading cause of death globally [9], and
Denmark has the highest COPD incidence rate among
the European countries [10]. COPD is an under-
diagnosed, irreversible and potentially life-threatening
condition where secondary prevention, treatment and
rehabilitation with systematic follow-up may help
control the symptoms, increase the patient’s quality of
life and delay disease progression [11]. Newly pub-
lished results indicate that 14.3% of people aged 35years and older have COPD [12]; yet, only 28% of
these people have been diagnosed [13].
In 2008, the Central Denmark Region implemented a
new disease management programme for COPD inspired
by the Chronic Care Model (CCM) [14]. However, imple-
mentation can be challenging, and knowledge about the ef-
fects of the implementation processes and their possible
effect on patients remains scarce [15,16]. Lugtenberg et al.
argue that active leadership is required to implement
change [17], and Greenhalgh states that targeted change
must be simple and adjustable to each locality [18]. Grol
et al. show that implementation in healthcare needs to in-
volve evidence-based information, few and precise recom-
mendations and practical advice to secure implementation
in clinical practice [19]. Several randomised studies have
reported that implementation of disease management
programmes for chronic conditions could reduce hospital
admissions, out-of-hours services and emergency depart-
ment attendance [20-24]. One cohort study found that
implementation of a disease management programme re-
duced readmissions to hospital [25], but only few studies
have examined the effectiveness of disease management
programmes targeting patients with COPD [26,27].
The aims were, first, to investigate the impact of the
previously developed active implementation model for a
disease management programme for COPD as measured
by specific indicators to determine to which degree the
GPs follow the recommendations; and, second, to deter-
mine the extent of healthcare utilization in primary and
secondary care for patients with COPD. The programme
was developed on the basis of the CCM [28].
Methods
Study design
The study was a block- and cluster-randomised controlled
trial with intervention and control groups and an additional
external control group. The intervention group consisted of
patients from half of the general practices in the
Ringkoebing-Skjern Municipality in Denmark. Patients
from the other half of the practices formed the control
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(Ikast-Brande) formed the external control group which
was established to control for a spillover effect of the inter-
vention conducted within the municipality [29,30]. To iden-
tify patients highly suspected for having COPD, we used a
validated COPD algorithm [31].
Setting
The study period spanned from November 2008 to
December 2010. The study was conducted in the
western part of the Central Denmark Region, where sec-
ondary care is provided by three regional hospitals in
Ringkoebing, Herning and Holstebro. Two comparable
municipalities in the region provided the setting for the
study.
All citizens living in Denmark are registered with a per-
sonal identification number, the CPR number. This allows
unique linkage between all the national registries at the
level of the individual [32]. The GPs are eligible for reim-
bursement of the services they provide and they must sub-
mit electronic reimbursement claims to the Danish
National Health Insurance Service Registry (DNHISR). In-
formation about all Danish citizens’ use of general practice
services, including out-of-hours services, can be obtained
from the DNHISR [33,34]. All hospitals must report out-
patient visits, contacts to the emergency department, hos-
pital admissions and discharges to the regional Patient
Administrative System (PAS) using International Classifica-
tion of Diseases (ICD-10) codes.
During the study period, the Ringkoebing-Skjern Mu-
nicipality had approximately 58,000 inhabitants of whom
35,000 were aged 35 or above. The municipality had 38
GPs organised into 15 practices. The neighbouring mu-
nicipality (Ikast-Brande) had close to 40,000 inhabitants
of whom 24,000 were aged 35 or above, and 25 GPs
organised into ten practices. In all practices, staff (i.e.
nurses, laboratory technicians or secretaries) employed
by the GPs conducted either the whole or a part of the
consultations on their own.
Intervention
The intervention practices undertook an active, structured
implementation of a disease management programme for
COPD. The intervention is depicted in the Additional file
1; we have described the development of the intervention
in detail elsewhere [35]. The intervention comprised com-
ponents from the main areas of the CCM - Policies and Re-
sources, Self-Management Support, Delivery System
Design, Organisation of Healthcare and Clinical Informa-
tion System [36]. To stimulate the process, we asked a local,
esteemed opinion leader to introduce and support the
intervention [37] both to GPs and to the municipality.
The intervention practices were invited to participate
in four two-and-a-half-hour sessions. The BreakthroughSeries [38,39] was used as a framework for the imple-
mentation of planned and targeted changes. All meetings
were chaired by experts and experienced facilitators,
who were all clinically educated and experienced in
aiding change in practice. One facilitator (MS) visited
each practice to explore and/or address challenges en-
countered in pursuing their goals.
We negotiated our implementation strategy with the mu-
nicipality, which took active ownership by increasing the
number of free COPD courses and smoking cessation
courses. The region agreed on providing a special reim-
bursement to GPs for joint home visits together with the
community nurse to newly discharged COPD patients [40].
Targeted self-management support for patients to cope
with exacerbations of the disease was an integral part of
our strategy, and we developed an action card with advice
to patients on management of sputum and exacerbations.
The action card was based on the research by Robert
Stockley [41,42].
To provide family, friends and the patients themselves
with more knowledge to improve their ability to cope with
their disease, we designed a web site with information
about COPD including contact details to the municipality,
patient support groups and the involved GPs.
The standard implementation of the disease manage-
ment programme from the Central Denmark Region
went ahead and thus also covered all the groups in our
study.Randomisation and sample size
Randomisation and allocation concealment
All GP practices were included in the study. An independ-
ent researcher drew slips that were matched to an elec-
tronic record of all GP practices in the Ringkoebing-Skjern
Municipality. The practices were block-randomised into
three blocks. The first block consisted of solo-practices;
three practices were drawn to the intervention group and
two to the control group. The second block consisted of
practices with two GPs; three practices were drawn to the
intervention group and two to the control group. The third
block consisted of practices with three or more GPs; three
practices were allocated to the intervention group and three
to the control group. In the external control group, there
were two solo-practices, three practices with two GPs and
four with three or more GPs. One practice with three GPs
was allocated to the intervention group as one of the GPs
was partly involved in the overall planning of the study.
Out of the nine invited intervention practices, seven ac-
cepted the invitation to participate. In accordance with the
intention-to-treat principle, the two practices that declined
the invitation to participate remained in the intervention
group. In total, 21 GPs were randomised to the intervention
group and 17 to the control group; the external control
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can be found in Table 1.
The allocation of both GPs and patients to the inter-
vention and the control group was open and known to
the GPs and also to the researchers as it was not pos-
sible to hide the allocation to the researchers who also
delivered the intervention to the GP practices.
Patients identified by the COPD algorithm from all
three groups were sent a baseline questionnaire and pa-
tients from the intervention group were also sent a flyer.
Furthermore, a poster was displayed in the practice
premises informing the patients that this practice was an
intervention practice. Only people coming into the
premises could see it. In Denmark, every citizen is listed
with a particular GP practice and can only use the ser-
vices from this practice, and patients rarely want to
change practice. It is most unlikely that a person would
change practice because of a poster.
Sample size
To detect a change from 50 to 60% in the proportion of
patients having a yearly follow-up consultation for their
chronic disease (with 80% power at the 0.05 level of sig-
nificance), a total of 816 patients with 408 in each group
would have to be included in the study. With a design
effect of 1.6, we would need 1,306 patients for the study.
The COPD algorithm
The COPD algorithm was validated in a previous study
which suggested that it could be used as a tool to iden-
tify patients with obstructive lung disease, primarily
COPD [31]. The search algorithm was based on admin-
istrative data on hospitalisation, redeemed prescriptions
for lung-related drugs and spirometries performed in the
GP practice; thus, the patients had already been in con-
tact with the healthcare system for a lung-related issue.
A prerequisite for identification was that the patient
should be 35 years old or older and be registered with aTable 1 Baseline characteristics for GPs as of 2008
N (%)
Male (%)
Mean age in years (min-max)*
Mean number of patients per GP (SD) *
No COPD CME** Attendance (%)
Did not routinely perform spirometry for smokers with symptoms (%)
Did not routinely stratify patients with COPD (%)
Did not routinely note the MRC score in the patient file (%)
Did not routinely provide prescription for antibiotics (%)
*p<0.001 Chi square test or linear regression model applied.
**CME COPD-related continued education.
#No questionnaire data from external control group.GP practice in the patient’s residing municipality. The
patients were identified either because they had been
hospitalised during the past five years with a lung-
related diagnosis, had redeemed prescriptions on lung
medication at least twice during the past year or had
had their lung function tested at their GP on two differ-
ent occasions during the past year.
Participants
The patient population comprised 3,021 patients from
the two municipalities who were identified by the COPD
algorithm [31]. Among these patients, 1,819 were from
the Ringkoebing-Skjern Municipality and 1,202 were
from the neighbouring municipality. Of the identified
patients, 2,895 had a GP in the municipality of their resi-
dence. At follow-up, 159 had died or sought research
protection. All patients received a questionnaire at base-
line. The study population consisted of responders who
confirmed their COPD diagnosis, called the CD popula-
tion. Patients who died during the intervention period
were excluded (Figure 1).
All patients followed their GPs’ allocation to interven-
tion, control group or external control group and would
only drop out of the study if their GP did so or if they
moved out of the municipality. No GP dropped out of
the study.
Data
The primary outcome was adherence to the disease
management programme in the GP practices. Adherence
was measured at the patient level in terms of use of the
specific services of planned and additional preventive
consultations, and the number of spirometries. The GP
practices report each of these services to the region to
be reimbursed.
The secondary outcome was use of out-of-hours ser-
vices, outpatient clinic and emergency department atten-
dances as well as hospital admissions. For admissions toIntervention Control Ext. control Total
21 (33.3) 17 (27.0) 25 (39.7) 63 (100)
14 (66.7) 13 (76.5) 13 (52.0) 40 (63.5)
51.6 (36–62) 49.2 (37–65) 51.6 (32–63) 50.9 (32–65)
1579 (210) 1290 (457) 1108 (295) 1296 (386)
4 (21.1) 5 (38.5) # #
10 (50.0) 4 (30.8) # #
9 (45.0) 6 (46.2) # #
15 (75.0) 10 (76.1) # #
18 (90.0) 11 (84.6) # #
N=18
Patients had died, sought research 
protection, not answered questionnaires or declared 
that they did not have COPD
N=1465
DEFINITION OF SUB-GROUP FOR SENSITIVITY ANALYSIS:





Patients had GP outside municipality
N=117 
1202
Ringkoebing-Skjern municipality Neighbouring municipality
1738 Patients eligible for the study
N=2904
Patients identified by the algorithm
N=3021
N=163 N=177
Patients declared that they did not have COPD
N=539  
538
Non-responders to 1st questionnaire















































Two GP practices were removed from the analysis as 





Figure 1 Flowchart for cluster-randomised study and patient flow in this and in the extra added group. Patient inclusion and exclusion
presented in numbers with percentage distribution indicated below numbers.
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sion concerning COPD within 30 days of the last
admission.
Register data
We collected data from the DNHISR [33,34] and the re-
gional PAS for all 2,736 patients identified by the COPD
algorithm from 1 November 2008 to 31 October 2010
(12 months before and 12 months after the start of the
intervention).
Questionnaire data
A baseline questionnaire was sent to all identified patients.
The questionnaire included validated tools to assess the pa-
tients’ respiratory state and mental health; their experience
of their health, care and practice (Medical Research Coun-
cil’s dyspnoea scale [43], the Major Depression Inventory
(MDI) [44], their self-reported health (EQ-5D) [45], the Pa-
tient Assessment of Chronic Illness Care (PACIC) [46] and
the Danish Patients Evaluate Practice (DanPEP) [47]). The
questionnaire also contained questions regarding use of
medication, support and socio-economic issues developed
on the basis of literature, clinical experience and interviews
with patients and healthcare professionals. Patients who
confirmed their diagnosis were sent a questionnaire at
follow-up. The results from the PACIC have been reported
elsewhere [48].
Analyses
The effect of the active implementation was analysed by
comparing the changes in the intervention group with
the changes in both the control group and the external
control group. For each of the outcomes, we calculated
yearly rates and rate ratios (RRs) between the year before
and the year after the intervention. To determine the
differences between the groups, the corresponding pair-
wise RRs between the groups were calculated. To facili-
tate estimation of the RRs, we used a binomial
regression model with log link when analysing each of
the following outcomes: proportion of planned prevent-
ive consultations, additional preventive consultations
and performed spirometries, as well as the proportion of
patients who had contact to the out-of-hours services,
who were admitted with or without a lung-related diag-
nosis and who had contact to the emergency depart-
ment. A negative binomial regression model allowing for
the heterogeneity between subjects [49] was used to ana-
lyse the counts of the following outcomes: conventional
consultations, contacts to the out-of-hours services, use
of bed days, contacts to the outpatient services with or
without a lung-related diagnosis, number of contacts to
the emergency department, number of admissions with
or without a lung-related diagnosis and number of
readmissions. Confidence intervals (CIs) at 95% wereassessed by performing robust variance estimation to ac-
count for a cluster effect at the GP level and, conse-
quently, also at the patient level. Adjustment was made
for age and gender, although this had minimal influence
on the estimates of interest.
We performed intention-to-treat analysis for the
algorithm-identified population and for the CD popula-
tion who had been identified by the algorithm and who
had themselves confirmed their diagnosis.
To examine the effectiveness and efficiency of the ac-
tive implementation model, we performed an additional
sensibility analysis where the two non-participating prac-
tices were omitted from the analysis and practices actu-
ally taking part in the intervention were analysed as
intervention practices; we called the sub-group with this
distribution of patients the EI population.
Analyses were performed using STATA version 11.0.
The trial was performed in accordance with the CON-
SORT statement extended for cluster-randomised con-
trolled trials [50].
Ethics
The study was recommended by the Committee of
Multipractice Studies in General Practice under the Da-
nish College of General Practitioners and by the Organisa-
tion of General Practitioners in Denmark (MPU 17–
2009). The study was approved by the Danish Data Pro-
tection Agency (J.nr. 2008-41-2855) and the Danish
Health and Medicines Authority (J.nr. 7-604-04-2/71
/EHE). The RCT was indexed at http://www.clinicaltrials.
gov/show/NCT01228708 (ID number: NCT01228708).
The present project did not require approval under the




The patients identified by the algorithm and those pa-
tients who also confirmed their COPD diagnosis, i.e. the
CD group, are characterised in Table 2. In the CD group,
the intervention group counted 458 (33.4%) patients, the
control group 376 (27.4%) patients and the external con-
trol group 538 (39.2%) patients. The EI population com-
prised 406 (29.6 %) patients in the intervention group,
376 (27.4%) patients in the control group and 538
(39.2%) patients in the external control group (Figure 1).
Primary outcome
Tables 3 and 4 show the changes in each group and the dif-
ferences in changes between the groups for the study popu-
lation. Data from the sub-group analysis are not shown.
The number of patients who had a planned preventive
consultation rose statistically significantly in the inter-
vention practices compared with the control practices
Table 2 Baseline data for patients as listed in the Danish Health Insurance Service Registry by 1 November 2008
Patients identified by COPD algorithm
Intervention Control Ext. control Total
N (%) 877 (32.1) 766 (28.0) 1,092 (39.9) 2,735 (100)
Men (%) 399 (45.5) 354 (46.2) 492 (45.0) 1,244 (45.5)
Female (%) 478 (54.5) 412 (53.8) 600 (55.0) 1,491 (54.5)
Mean age (min-max) 63.9 (35–97) 63.3 (35–96) 63.3 (35–101) 63.5 (35–101)
CD Population
Patients identified by algorithm who confirmed that they had COPD
Intervention Control Ext. control Total
n (%) 458 (33.4) 376 (27.4) 538 (39.2) 1,372 (100)
Proportion of N (%) 52.2 49.1 49.3 50.2
Mean age (min-max) 222 (48.5) 179 (47.6) 264 (49.1) 665 (48.5)
Men (%) 236 (51.5) 197 (52.4) 274 (50.9) 707(51.5)
Female (%) 67.6 (36–91) 66.3 (35–91) 66.7 (36–94) 66.9 (35–94)
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additional preventive consultations (RR=2.03, p=0.004)
and more had a spirometry at least once a year
(RR=1.36, p=0.006).
Interestingly, the use of conventional consultations de-
creased among the patients in the intervention group,
while an increase was seen in the control group; thus,
there was a statistically significant difference in use of
conventional consultations (RR=0.85, p=0.005).Secondary outcome
Patients from the control group made more contacts to
the out-of-hours services at the end of the study period
than in the beginning (IRR=1.22, p=0.032). No difference
in the change of contacts to out-of-hours services was
observed between the intervention group and the con-
trol groups.
Fewer patients from the intervention group were ad-
mitted without a lung-related diagnosis than in the con-
trol group (RR=0.71, p=0.018); and fewer patients from
the intervention group were readmitted than in the ex-
ternal control group (IRR=0.33, p=0.003). The use of
hospital bed days did not change in the intervention
group; whereas it rose in the control group (IRR=1.35,
p=0.008).
Although patients from the external control group vis-
ited the outpatient services more at the end of the study
period (IRR=1.41, p=0.002), there was no difference in
the change in visits to the outpatient services between
the intervention group and either the control group or
the external control group.
No difference was observed in the three groups’ use of
emergency department services before and after the
intervention.Sensitivity analyses
The results of the analysis in which the data from the
two practices that did not participate in the intervention
were removed were fairly similar to the findings reported
above although there were two new findings: more patients
in the intervention group than in the control group had an
additional preventive consultation (RR=1.95, p=0.049) and
the number of acute admissions in the intervention group
fell to less than half (RR=0.43, p=0.002) (data not shown).
The same was the case for the results for the population
identified by the algorithm both for the intention-to-treat
and the sensitivity analysis (data not shown). For the popu-
lation identified by the algorithm, the intention-to-treat
analysis showed the same number of readmissions in the
intervention group after the active implementation, but the
number of readmissions rose in both the control group and




Our study showed an effect of the intervention on planned
and additional preventive consultations, performed spirom-
etries and admissions. Thus, the intervention changed the
management of patients with COPD.
Strength and limitations of the study
This study draws strength from its randomised design,
the high number of included GPs and patients, and the
use of highly valid administrative data. The results have
been analysed both for the population identified by the
COPD algorithm and for the study population where pa-
tients had confirmed their diagnosis. It adds to the
strength of the study that the study population’s results
were either reproduced in the sub-group analysis or even
















Number of patients who had a planned preventive 2008-09 0.34 0.27;0.44 0.24 0.17;0.33 0.25 0.14;0.45 1.43 0.96;2.13 1.35 0.72;2.52 0.95 0.49;1.81
consultation 2009-10 0.53 0.42;0.68 0.21 0.15;0.30 0.29 0.17;0.48 2.521 1.62;3.92 1.841 1.05;3.24 0.73 0.39;1.36
RR 1.552 1.23;1.96 0.88 0.69;1.12 1.14 0.91;1.42 1.772 1.26;2.48 1.36 0.98;1.88 0.77 0.55;1.07
Number of patients who had an additional 2008-09 0.11 0.05;0.27 0.06 0.03;0.14 0.10 0.06;0.18 1.86 0.56;6.17 1.09 0.39;3.07 0.59 0.22;1.55
preventive consultation 2009-10 0.23 0.11;0.48 0.08 0.03;0.21 0.12 0.07;0.24 3.00 0.87;10.35 1.86 0.70;4.91 0.62 0.19;2.03
RR 2.032 1.26;3.27 1.26 0.84;1.89 1.19 0.84;1.71 1.61 0.86;3.01 1.70 0.94;3.09 1.05 0.62;1.81
Number of patients who had a spirometry 2008-09 0.33 0.26;0.41 0.23 0.16;0.33 0.22 0.17;0.28 1.43 0.92;2.23 1.481 1.05;2.08 1.03 0.66;1.63
performed at the GP practice 2009-10 0.45 0.34;0.58 0.24 0.16;0.36 0.22 0.15;0.34 1.821 1.23;2.94 2.011 1.23;3.01 1.10 0.62;1.96
RR 1.361 1.09;1.70 1.07 0.85;1.34 1.00 0.70;1.44 1.27 0.93;1.75 1.36 0.89;2.08 1.07 0.70;1.64
Number of patients who were admitted to hospital 2008-09 0.24 0.20;0.29 0.21 0.17;0.26 0.24 0.21;0.28 1.16 0.86;1.55 1.01 0.80;1.29 0.88 0.67;1.15
without a lung-related diagnosis 2009-10 0.22 0.18;0.26 0.26 0.23;0.30 0.26 0.21;0.31 0.82 0.66;1.02 0.83 0.64;1.07 1.01 0.81;1.26
RR 0.88 0.74;1.05 1.24 0.99;1.56 1.08 0.92;1.26 0.712 0.53;0.94 0.82 0.65;1.03 1.15 0.87;1.52
1Statistical significance p ≤ 0.05.
2Statistical significance p ≤ 0.005.


































Consultations with GP (daytime) 2008-09 7.75 6.76-8.87 7.57 6.43-8.92 6.75 6.24-7.29 1.02 0.83-1 1.15 0.98-1.34 1.12 0.94-1.34
2009-10 7.34 6.60-8.17 8.50 7.12-10.14 7.28 6.73-7.88 0.86 0.71-1 1.01 0.88-1.15 1.17 0.96-1.41
IRR 0.95 0.88-1.02 1.122 1.08-1.17 1.082 1.02-1.44 0.852 0.78-0 0.881 0.80-0.96 1.04 0.97-1.12
Contacts to out-of-hours services 2008-09 0.68 0.47-0.98 0.60 0.42-0.86 0.61 0.51-0.74 1.12 0.66-1 1.10 0.73-1.66 0.99 0.66-1.47
2009-10 0.69 0.47-1.01 0.74 0.56-0.98 0.56 0.46-0.68 0.93 0.60-1 1.23 0.83-1.83 1.32 0.94-1.85
IRR 1.02 0.85-1.22 1.221 1.02-1.48 0.92 0.78-1.08 0.83 0.64-1 1.12 0.88-1.42 1.341 1.05-1.71
Admissions with another diagnosis 2008-09 0.35 0.27-0.45 0.36 0.28-0.46 0.33 0.28-0.38 0.97 0.68-1 1.06 0.79-1.43 1.10 0.82-1.46
2009-10 0.33 0.27-0.41 0.47 0.38-0.58 0.45 0.36-0.56 0.701 0.52-0 0.74 0.55-1.01 1.06 0.78-1.43
IRR 0.95 0.69-1.32 1.31 0.91-1.88 1.361 1.06-1.74 0.73 0.44-1 0.70 0.47-1.05 0.96 0.62-1.49
Bed days 2008-09 1.56 1.09-2.22 2.07 1.55-2.63 1.48 1.11-1.98 0.77 0.49-1 1.05 0.67-1.63 1.36 0.90-2.06
2009-10 1.61 1.33-1.96 1.70 1.26-2.29 2.01 1.59-2.56 0.95 0.66-1 0.80 0.60-1.07 0.84 0.58-1.23
IRR 1.04 0.69-1.56 0.84 0.64-1.11 1.361 1.09-1.70 1.23 0.75-2 0.76 0.48-1.21 0.621 0.43-0.89
Readmissions^ 2008-09 0.07 0.05-0.12 0.13 0.10-0.17 0.05 0.04-0.08 0.561 0.33-0 1.38 0.78-2.47 2.452 1.53-3.94
2009-10 0.07 0.05-0.09 0.12 0.06-0.21 0.14 0.11-0.19 0.59 0.30-1 0.481 0.32-0.72 0.82 0.42-1.60
IRR 0.95 0.55-1.63 0.90 0.50-1.64 2.712 1.90-3.86 1.05 0.46-2 0.352 0.18-0.66 0.332 0.16-0.68
Contacts to outpatient services with any 2008-09 3.07 2.70-3.48 3.38 2.83-4.03 3.03 2.59-3.54 0.91 0.73-1 1.01 0.84-1.22 1.12 0.88-1.42
diagnosis 2009-10 2.91 2.55-3.34 3.68 3.30-4.11 3.65 2.96-4.49 0.792 0.67-0 0.80 0.63-1.01 1.01 0.80-1.27
IRR 0.95 0.81-1.11 1.09 0.95-1.25 1.202 1.22-1.29 0.87 0.71-1 0.781 0.66-0.94 0.90 0.78-1.04
Contacts to outpatient services with 2008-09 0.16 0.11-0.24 0.28 0.19-0.40 0.19 0.12:0.30 0.591 0.35-0 0.86 0.48-1.57 1.47 0.83-2.62
a lung-related diagnosis 2009-10 0.22 0.13:0.36 0.28 0.17-0.46 0.26 0.19-0.38 0.78 0.67-0 0.83 0.45-1.54 1.07 0.59-1.92
IRR 1.35 0.76-2.40 1.02 0.67-1.54 1.412 1.13-1.74 1.33 0.65-2 0.95 0.51-1.81 0.72 0.46-1.15
^A readmission was defined as an acute admission within 30 days of the last admission.
1Statistical significance p < 0.05.
2Statistical significance p < 0.005.











































Smidth et al. BMC Health Services Research 2013, 13:385 Page 10 of 12
http://www.biomedcentral.com/1472-6963/13/385enhanced. A further strength springs from the fact that a
strong trend towards the same results was identified in
the analysis of the population identified by the algorithm
alone.
The two practices with four GPs who declined to
participate in the intervention were excluded in a sub-
group analysis because we wanted to examine the effect-
iveness of the active implementation model. These two
practices received none of the components of the active
implementation. This could give rise to selection bias.
However, the sub-group analysis showed an overall pat-
tern very close to that of the intention-to-treat analysis,
which assured us that this bias is not decisive.
In order to accommodate analyse changes over time
we chose to exclude those patients who died during the
trial. In case of large differences in mortality between
groups, this could affect the results of the comparison of
health care use in either direction. However, the nature
of the intervention and the nature of the relatively slowly
evolving disease convinced us that any influence of the
intervention on the endpoint “death” would be negligible
in a short-term perspective. This assumption was con-
firmed by the present data.
We did consider if research protection could be an
issue for patients in the randomised groups. One could
think that patients might tire of being contacted. Both
the intervention group and the control group were ex-
posed to the baseline and the follow-up questionnaire,
but only intervention patients received a flyer with the
questionnaire; this would hardly trigger an action to seek
research protection.The present data show that the issue
of research protection played only a negligible role for
participation.
The use of a complex intervention [35] building on
specific aspects of the CCM [3,4] represented a special
challenge. For example, we were unable to assess the ef-
fectiveness of the individual components of the interven-
tion. The implementation was offered as a package and
was evaluated as such even though each individual GP
practice may have selected only particular elements from
the full catalogue. This may have introduced variation as
to which elements actually brought change. However, in
these respects, the present implementation processes
were in no way different from similar implementation
processes in the healthcare system.
Despite our efforts to identify as many of the patients
with known COPD as possible, our study is underpow-
ered. We were only able to identify those patients who
had been in contact with the healthcare system and for
whom lung-related complaints had resulted in an action
on the part of the healthcare system. When a method to
detect COPD in the earlier stages has been developed,
patients with milder degrees of COPD can be included
in the analyses. This will allow us to conduct a study ofa larger scale; alternatively, the study can be extended to
more municipalities participating in the randomised
study.
An independent person randomised GP practices to
the intervention or the control group. However, after the
randomisation, we could not conceal the allocation to
the researchers who performed the analysis because this
group of researchers was also the one which conducted
the intervention with the intervention practices. This
could be considered a flaw in the study design.
One weakness of the present intervention, which is
shared by most health services research, is that some
intervention elements (e.g. recruitment of patients for
the courses) were available for patients from the entire
Ringkoebing-Skjern Municipality and not exclusively for
patients from the intervention practices. This may lead
to a serious underestimation of the effect and could
imply that we have found the least possible difference
between the study groups.
The understanding of the intervention could have
been enhanced by including a process evaluation com-
ponent into the study. For example, we could have
interviewed the patients and/or the health professionals.
The added external control group further strengthened
the study because it allowed us to check the spillover ef-
fect within the CME groups and in the common health
services for all COPD patients.
Comparison with other studies
Other studies have shown similar effects of targeted,
planned and evidence-based interventions for patients
with chronic conditions [51-53] even when the impact
was measured after ten years [54], whereas others have
found no effects [55]. One meta-analysis suggests that
comparing implementation strategies may establish
sound evidence for the effectiveness of the successful
implementation of programmes [56].
In a systematic review of the use of the CCM for
COPD prevention and management, Adams et al. drew
the conclusion that patients with COPD who received
two or more components of the CCM had fewer un-
scheduled/emergency-room visits, fewer hospitalisations
and showed a trend towards reduced healthcare costs
compared with the control groups [57]. We made a
similar observation, even if the effect on the use of the
emergency department visits was minimal and we used
healthcare utilization as a proxy for healthcare costs.
The intervention with the components that we se-
lected is directly transferrable and applicable in future
multifaceted interventions for chronic conditions in gen-
eral practice.
Our finding of less use of hospital services after active
implementation of a disease management programme is
highly relevant as other studies have shown an increase
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compared with patients without COPD [58].
Unanswered questions and future research
The study period was two years with one year before the
intervention start and one year after. The effect may have
been different if the study had covered a longer period of
time.
We measured healthcare utilization as a proxy for eco-
nomic evaluation. A detailed and more comprehensive ana-
lysis, including the costs of the implementation, is needed.
Consideration of the economic aspects of the active imple-
mentation of optimised healthcare for patients with COPD
would also be of future interest.
The study would benefit from a deeper look into the
black box of the intervention. An added process evaluation
component could provide such insight as would also a fu-
ture study with interviews with patients and/or with
healthcare professionals. Another future study could in-
clude the component in a mixed methods study.
Multimorbidity is often the norm in general practice. A
strategy like the implementation model used in the present
study may be an effective tool to coordinate healthcare ser-
vices for patients with multimorbidity. A future study in-
cluding patients with multimorbidity would be of much
interest to clinicians and politicians.
Our findings in this randomised study and the success of
similar programmes for other chronic diseases highlight the
potential and the need for larger long-term studies. Such
studies should explore activities and implementation strat-
egies that could easily be adopted in GP practices and
should comprise multiple components of the CCM with a
view to preventing complications and improving outcomes
for patients with COPD.
Conclusions
The multifaceted implementation of a disease management
programme for COPD made general practice follow the
programme and proactively perform follow-up consulta-
tions and spirometries. This resulted in a decline in the
number of GP consultations and a tendency towards de-
creased use of hospital services. Use of out-of-hours ser-
vices remained the same although patients from the control
group increased their use of these services. No effect on the
use of the emergency department was found. The imple-
mentation model can be applied in future multifaceted in-
terventions targeting patients with chronic disease.
Additional file
Additional file 1: The PaTPlot depicting the timeline and the
contents of the active implementation model. Squares illustrate fixed
object, e.g. printed materials like questionnaires. Circles illustrate an activity
was involved in the component, e.g. Continuing Medical Education
meetings.Abbreviations
AT: As treated; CCM: Chronic Care Model; CD: Confirmed Diagnosis;
CI: Confidence Interval; COPD: Chronic Obstructive Pulmonary Disease;
GP: General Practitioner.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
FO, PV and MS designed the study. MS, PV, FO and MBC participated in the
study and in drafting the manuscript. MFG assisted with statistical analysis
and in drafting the manuscript. All authors have read and approved the final
manuscript.
Acknowledgements
The study was carried out at the Research Unit for General Practice in Aarhus
and further funded by the Ringkoebing-Skjern Municipality, the Central
Denmark Region and the Medical Research Fund at Aarhus University,
Denmark.
We are grateful to patients, GPs and Sundhedscenter Vest of the
Ringkoebing-Skjern Municipality for participating in the study. We thank Dr.
Robert Stockley, University of Birmingham, United Kingdom, for permission
to use his sputum chart and Dr. Erik Juul Jensen, Hospitalsenheden Vest, the
Central Denmark Region, for providing support during the intervention. We
wish to thank GP Lars Foged, the town of Skjern, and Director Ulla Svendsen,
Sundhedscenter Vest of the Ringkoebing-Skjern Municipality, and Chief
Consultant Steen Vestergaard-Madsen, the Central Denmark Region for
supporting the idea.
Received: 21 February 2013 Accepted: 16 September 2013
Published: 3 October 2013
References
1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology
of multimorbidity and implications for health care, research, and
medical education: a cross-sectional study. Lancet 2012, 380:7–9.
2. Danske regioner: Fremtidens Almen Praksis; 2010. http://www.regioner.dk/
Publikationer/Sundhed+og+sygehuse/~/media/migration%20folder/upload/
filer/sundhed/praksis%20magasin%20web_med%20ny%20forside.pdf.ashx.
(The Future's General Practice) [In Danish].
3. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for
patients with chronic illness. JAMA 2002, 288:1775–9.
4. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for patients
with chronic illness: the chronic care model, Part 2. JAMA 2002, 288:1909–14.
5. Wagner EH, Austin BT, Von KM: Improving outcomes in chronic illness.
Manag Care Q 1996, 4:12–25.
6. Feachem RG, Sekhri NK, White KL: Getting more for their dollar: a
comparison of the NHS with California's Kaiser Permanente.
BMJ 2002, 324:135–41.
7. Vondeling H: Economic evaluation of integrated care: an introduction.
Int J Integr Care 2004, 4:e20.
8. Wennberg J, Gittelsohn A: Variations in medical care among small areas.
Sci Am 1982, 246:100–11.
9. World Health Organization: WHO Disease and injury country estimates; 2009.
http://www.who.int/healthinfo/global_burden_disease/estimates_country/
en/index.html.
10. Christensen K, Bjørk C, Vinther-Larsen M, Løkkegaard E, Grønbæk M: Otte
folkesygdomme - Forekomst og udvikling. (Eight prevalent diseases - Incidence and
progression), [In Danish]. København: Statens Institut for Folkesundhed; 2005.
11. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS: Global strategy for the
diagnosis, management, and prevention of chronic obstructive
pulmonary disease: National Heart, Lung, and Blood Institute and World
Health Organization Global Initiative for Chronic Obstructive Lung
Disease (GOLD): executive summary. Respir Care 2001, 46(8):798–825.
12. Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J: Developing COPD: a
25 year follow up study of the general population. Thorax 2006, 61:935–9.
13. Hansen JG, Pedersen L, Overvad K, Omland O, Jensen HK, Sorensen HT:
Prevalence of chronic obstructive pulmonary disease–secondary
publication. Ugeskr Laeger 2009, 171:2986–8.
14. Midtjylland R: Forløbsprogram for Kronisk Obstruktiv Lungesygdom - Kliniske
retningslinjer, tjeklister og vejledninger. Viborg: Region Midtjylland; 2008. (Disease
Smidth et al. BMC Health Services Research 2013, 13:385 Page 12 of 12
http://www.biomedcentral.com/1472-6963/13/385management programme for COPD - Clinical guidelines, checklists and
guidelines), [In Danish].
15. Grol R, Wensing M: What drives change? Barriers to and incentives for
achieving evidence-based practice. Med J Aust 2004,
180(6 Suppl):S57–S60.
16. Grol R, Grimshaw J: From best evidence to best practice: effective
implementation of change in patients' care. Lancet 2003, 362:1225–30.
17. Lugtenberg M, Burgers JS, Westert GP: Effects of evidence-based clinical
practice guidelines on quality of care: a systematic review.
Qual Saf Health Care 2009, 18:385–92.
18. Greenhalgh T, Robert G, Bate P, Macfarlane F, Kyriakidou O: Diffusion of
Innovations in Health Service Organisations. A systematic literature review.
Oxford: Blackwell Publishing; 2005.
19. Grol R: Changing physicians' competence and performance: finding the
balance between the individual and the organization. J Contin Educ Health Prof
2002, 22:244–51.
20. Nolte E, McKee M: Measuring the health of nations: analysis of mortality
amenable to health care. BMJ 2003, 327:1129.
21. Lorig KR, Ritter P, Stewart AL, Sobel DS, Brown BW Jr, Bandura A, Gonzalez
VM, Laurent DD, Holman HR: Chronic disease self-management program:
2-year health status and health care utilization outcomes. Med Care 2001,
39:1217–23.
22. Gadoury MA, Schwartzman K, Rouleau M, Maltais F, Julien M, Beaupre A,
Renzi P, Begin R, Nault D, Bourbeau J: Self-management reduces both
short- and long-term hospitalisation in COPD. Eur Respir J 2005, 26:853–7.
23. Hendriks JL, Nieuwlaat R, Vrijhoef HJ, De WR, Crijns HJ, Tieleman RG: Improving
guideline adherence in the treatment of atrial fibrillation by implementing an
integrated chronic care program. Neth Heart J 2010, 18:471–7.
24. Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R: Does
diabetes disease management save money and improve outcomes? A
report of simultaneous short-term savings and quality improvement
associated with a health maintenance organization-sponsored disease
management program among patients fulfilling health employer data
and information set criteria. Diabetes Care 2002, 25:684–9.
25. Condelius A, Hallberg IR, Jakobsson U: Hospital and outpatient clinic
utilization among older people in the 3–5 years following the initiation
of continuing care: a longitudinal cohort study. BMC Health Serv Res 2011,
11:136.
26. Rabe KF: Guidelines for chronic obstructive pulmonary disease treatment
and issues of implementation. Proc Am Thorac Soc 2006, 3:641–4.
27. Sin DD, Bell NR, Svenson LW, Man SF: The impact of follow-up physician
visits on emergency readmissions for patients with asthma and chronic
obstructive pulmonary disease: a population-based study. Am J Med
2002, 112:120–5.
28. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A:
Improving chronic illness care: translating evidence into action.
Health Aff (Millwood) 2001, 20:64–78.
29. Fletcher RH, Fletcher SW, Wagner EH: Clinical Epidemiology. The Essentials.
3rd edition. Baltimore: Williams & Wilkins; 1996.
30. Verstappen WH, Van der WT, G TR, Grimshaw J, Winkens R, Grol RP: Block
design allowed for control of the Hawthorne effect in a randomized
controlled trial of test ordering. J Clin Epidemiol 2004, 57:1119–23.
31. Smidth M, Sokolowski I, Kærsvang L, Vedsted P: Developing an algorithm
to identify people with Chronic Obstructive Pulmonary Disease (COPD)
using administrative data. BMC Med Inform Decis Mak 2012, 12:38.
32. Pedersen CB: The Danish Civil Registration System. Scand J Public Health
2011, 39(7 suppl):22–5.
33. Sahl Andersen J, De Fine ON, Krasnik A: The Danish National Health
Service Register. Scand J Public Health 2011, 39(7 suppl):34–7.
34. Flarup L, Moth G, Christensen MB, Vedsted P, Olesen F: Den danske lægevagt i
internationalt perspektiv - en sammenlignende undersøgelse af lægevagt i Danmark,
England, Holland, Norge og Sverige. 1st edition. Aarhus: Forskningsenheden for
Almen Praksis, Aarhus Universitet; 2010. (The Danish out-of-hours service in an
international perspective - a comparative study of out-of-hours services in
Denmark, United Kingdom, The Netherlands, Norway and Sweden), [In Danish].
35. Smidth M, Christensen MB, Olesen F, Vedsted P: Developing an active
implementation model for a chronic disease management program.
Int J Integr Care. in press.
36. Wagner EH: Chronic disease management: what will it take to improve
care for chronic illness? Eff Clin Pract 1998, 1:2–4.37. Stross JK: The Educationally Influential Physician. J Contin Educ Health Prof
1996, 16:167–72.
38. Improving chronic illness care. http://www.improvingchroniccare.org/index.
php?p=About_US&s=6. 2-5-2012.
39. Langley GJ, Nolan KM, Nolan TW, Clifford LN, Provost LP: The Improvement
Guide: A Practical Approach to Enhancing Organizational Performance.
San Francisco: Jossey-Bass; 1996.
40. Wensing M, van der Weijden T, Grol R: Implementing Guidelines and
innovations in general practice: which interventions are effective?
Brit J Gen Pract 1998, 48:991–997.
41. Stockley RA, O'Brien C, Pye A, Hill SL: Relationship of sputum color to nature
and outpatient management of acute exacerbations of COPD. Chest 2000,
117:1638–45.
42. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA: Changes in bronchial
inflammation during acute exacerbations of chronic bronchitis.
Eur Respir J 2001, 117:1112–9.
43. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of
the Medical Research Council (MRC) dyspnoea scale as a measure of
disability in patients with chronic obstructive pulmonary disease. Thorax 1999,
54:581–6.
44. Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P: The internal and
external validity of the Major Depression Inventory in measuring severity
of depressive states. Psychol Med 2003, 33:351–6.
45. Sorensen J, Davidsen M, Gudex C, Pedersen KM, Bronnum-Hansen H:
Danish EQ-5D population norms. Scand J Public Health 2009, 37:467–74.
46. Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM:
Development and validation of the Patient Assessment of Chronic Illness
Care (PACIC). Med Care 2005, 43:436–44.
47. Vedsted P, Sokolowski I, Heje HN: Data quality and confirmatory factor
analysis of the Danish EUROPEP questionnaire on patient evaluation of
general practice. Scand J Prim Health Care 2008, 26:174–80.
48. Smidth M, Olesen F, Fenger-Grøn M, Vedsted P: Patient-experienced effect
of an active implementation of a disease management programme for
COPD - a randomised trial. BMC Fam Pract 2013, 14:147.
49. Thomsen JL, Parner ET: Methods for analysing recurrent events in health
care data. Examples from admissions in Ebeltoft Health Promotion
Project. Fam Pract 2006, 23:407–13.
50. Campbell MK, Elbourne DR, Altman DG: CONSORT statement: extension to
cluster randomised trials. BMJ 2004, 328:702–8.
51. Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M:
When is it cost-effective to change the behavior of health professionals?
JAMA 2001, 286:2988–92.
52. Tsai AC, Morton SC, Mangione CM, Keeler EB: A meta-analysis of interventions
to improve care for chronic illnesses. Am J Manag Care 2005, 11:478–88.
53. McLean S, Chandler D, Nurmatov U, Liu J, Pagliari C, Car J, Sheikh A:
Telehealthcare for asthma: a Cochrane review. CMAJ 2011,
183:E733–E742.
54. Ogden T, Bjornebekk G, Kjobli J, Patras J, Christiansen T, Taraldsen K, Tollefsen N:
Measurement of implementation components ten years after a nationwide
introduction of empirically supported programs - a pilot study. Implement Sci
2012, 31(7):49.
55. Brand C, Landgren F, Hutchinson A, Jones C, Macgregor L, Campbell D: Clinical
practice guidelines: barriers to durability after effective early implementation.
Intern Med J 2005, 35:162–9.
56. Francke AL, Smit MC, De Veer AJ, Mistiaen P: Factors influencing the
implementation of clinical guidelines for health care professionals: a
systematic meta-review. BMC Med Inform Decis Mak 2008, 8:38.
57. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE: Systematic
review of the chronic care model in chronic obstructive pulmonary
disease prevention and management. Arch Intern Med 2007, 167:551–61.
58. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB: Health
care utilization in chronic obstructive pulmonary disease. A case–control
study in a health maintenance organization. Arch Intern Med 2000,
160:2653–8.
doi:10.1186/1472-6963-13-385
Cite this article as: Smidth et al.: The effect of an active implementation
of a disease management programme for chronic obstructive
pulmonary disease on healthcare utilization - a cluster-randomised
controlled trial. BMC Health Services Research 2013 13:385.
